Larvol Delta - ASLAN-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update

eblasakimab (ASLAN004) - ASLAN Pharma

https://www.globenewswire.com/news-release/2023/03/24/2633886/0/en/ASLAN-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html

Mar 24, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next